Status: Phase 2
Entry Type: Antibody
Molecule Category: UNKNOWN

Indications

Mesh Heading Maximum Phase Reference
Neoplasms Phase 2 ClinicalTrials
Lymphoma Phase 1/Phase 2 ClinicalTrials
CONTENTS